Dr. Stanley Thomas Carmichael, MD

Dr. Carmichael practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Carmichael's NPI, 1093730921, was assigned on July 13, 2006. Dr. Carmichael graduated from WashU Medicine in 1994. Dr. Carmichael's California license number on file is G84514.

Dr. Carmichael's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Carmichael's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Carmichael is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Neurology. Dmand AI also links Dr. Carmichael to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carmichael practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Carmichael's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Carmichael is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Carmichael has a license on file in California.

Dmand AI lists mobility impairment and parkinson's disease among the conditions Dr. Carmichael treats.

CMS data shows 23 Medicare services from Dr. Carmichael across 1 procedure code in 2023, for 21 Medicare patients. Medicare paid $1,536 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Carmichael in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carmichael's median patient age at 76, with 46% women.

In 2024, Dr. Carmichael wrote 45 Medicare Part D claims for 11 patients. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $3 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Carmichael for performance year 2024, reported as part of a group. Dr. Carmichael accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Carmichael, published from 2010 to 2019. The most frequent topics are Stroke, Stroke Rehabilitation and Research Design. Dr. Carmichael has published most often in Neurorehabil Neural Repair. Dr. Carmichael's most frequent co-authors are Steven C. Cramer, MD, Daniel Hal Geschwind, MD and Diana Katsman, MD.

CMS Open Payments shows 2 general payments to Dr. Carmichael from 2 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $95.

Dmand AI lists 7 awards for Dr. Carmichael, most recently Viste Award in 2019.

Dr. Carmichael graduated from WashU Medicine in 1994. Dr. Carmichael is a member of AAN.

Dr. Carmichael is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.